Summit Therapeutics Inc.SMMTNASDAQ
LOADING
|||
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.00
Net Income/Share$-1.24
Operating CF/Share$-0.37
Free CF/Share$-0.37
Cash/Share$0.32
Book Value/Share$0.26
Tangible Book/Share$0.26
Equity/Share$0.26
Interest Debt/Share$0.01
CapEx/Share$0.00
Dividend/Share$0.00
Valuation
Market Cap$10.70B
Enterprise Value$10.46B
P/E Ratio-11.59P/S Ratio0.00P/OCF Ratio-39.33
P/FCF Ratio-39.31
P/B Ratio55.56P/TB Ratio55.56
EV/Sales0.00EV/EBITDA-11.36
Graham Valuation
Graham Number--
Graham Net-Net$0.23
Profitability
Earnings Yield-8.63%FCF Yield-2.54%ROE-311.15%ROIC-468.68%Return on Tangible Assets-354.84%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-0.19%
CapEx/Revenue0.00%
CapEx/Depreciation-0.13
SBC/Revenue0.00%
SG&A/Revenue0.00%
R&D/Revenue0.00%
Liquidity & Solvency
Debt/Equity0.03Debt/Assets0.02Debt/Market Cap0.00
Net Debt/EBITDA0.25
Current Ratio3.80Interest Coverage-103901.44xIncome Quality0.29Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding540 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.68x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$190.26M
Working Capital$181.54M
Invested Capital$189.77M
Intangibles/Assets0.76%